Last Updated on October 2, 2024 by The Health Master
New Delhi: Lupin said its American subsidiary has received approval from the US Food and Drug Administration (USFDA) to market a generic product used for the treatment of skin issues.
New Jersey-based Novel Laboratories Inc. has received approval from the USFDA for Fluocinolone Acetonide Topical Oil, Lupin said in a statement.
The product is the generic version of Hill Dermaceuticals Inc.’s Derma-Smoothe/FS Topical Oil.
Lupin said the product will be manufactured at its Somerset facility in the US.
As per the IQVIA MAT March 2023 data, Fluocinolone Acetonide Topical Oil had estimated annual sales of USD 9 million in the US.
Lupin shares were trading 0.67 percent lower at Rs 981.65 apiece on the BSE.
USFDA gives approval for Saxagliptin Tablets
USFDA gives approval for Saxagliptin Tablets
USFDA gives marketing approval for this Birth Control Pill
USFDA gives nod to market this cancer treatment generic injection
USFDA gives approval for Plerixafor injection
USFDA gives approval this drug as first treatment for a type of skin infection
Drug Dept cautions consumers about 15 NSQ drugs in circulation: Karnataka
Govt prohibits Ketoprofen and Aceclofenac formulations for Animal Use
USFDA gives approval for Saxagliptin Tablets
Govt to implement GMP for Pharma Companies to enhance quality and global acceptance
DCGI asks manufacturers: Not to submit same batch of cough syrup to multiple Laboratories
NIPER: A Comprehensive Guide to NIPER Institutes in India
3D printed Medical Device developed for rapid diagnosis of UTI
Illegal Drugs worth more than Rs. 50 Lakh seized from warehouses in Agra
Latest on Indian Pharmacopoeia Commission (IPC)
Lok Sabha passes The Jan Vishwas Bill to Amend Drugs and Cosmetics Act
